πŸ‡ΊπŸ‡Έ FDA
Patent

US 10696689

Somatostatin modulators and uses thereof

granted A61KA61K47/14A61K9/0014

Quick answer

US patent 10696689 (Somatostatin modulators and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRINETICS PHARMACEUTICALS, INC.
Grant date
Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/14, A61K9/0014, A61K9/0019, A61K9/0095